Acquisition Announced
HS North America acquisition of Aptose Biosciences
Announced 18 Nov 2025
Advisers
- Target
- Aptose Biosciences
- Acquirer
- HS North America
- Target based in
- Canada
- Buyer based in
- United States (unverified)
- Sector
- Biotech
- Tags
- Biotech, Oncology, Drug Development
In the league tables
Similar deals
- GSK acquisition of trispecific T cell-engager (TCE) asset Sep 2026 · US$750m · Biotech
- Passage Bio and Remix Therapeutics merger Jun 2026 · Biotech
- GSK acquisition of Nuvalent Jun 2026 · US$11bn · Biotech
- Treeline Biosciences and Standard BioTools merger Jun 2026 · US$460m · Biotech
- Rallybio acquisition of Avenzo Therapeutics Jun 2026 · Biotech
Sources
- 24 Feb 2026 Definitive merger proxy statement (DEFM14A), Aptose Biosciences Inc. sec.gov